Correction to: InRange: Comparison of the Second-Generation Basal Insulin Analogues Glargine 300 U/mL and Degludec 100 U/mL in Persons with Type 1 Diabetes Using Continuous Glucose Monitoring-Study Design.

Journal

Diabetes therapy : research, treatment and education of diabetes and related disorders
ISSN: 1869-6953
Titre abrégé: Diabetes Ther
Pays: United States
ID NLM: 101539025

Informations de publication

Date de publication:
Aug 2020
Historique:
pubmed: 25 6 2020
medline: 25 6 2020
entrez: 25 6 2020
Statut: ppublish

Résumé

In the original publication, the timing of baseline CGM assessment was incorrectly stated.

Identifiants

DOI: 10.1007/s13300-020-00853-7 PMID: 32578133 PMC: PMC7376792
pubmed: 32578133
doi: 10.1007/s13300-020-00853-7
pii: 10.1007/s13300-020-00853-7
pmc: PMC7376792
doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1907-1908

Commentaires et corrections

Type : ErratumFor

Auteurs

Tadej Battelino (T)

UMC-University Children's Hospital, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia. tadej.battelino@mf.uni-lj.si.

Zsolt Bosnyak (Z)

Sanofi S.A., Paris, France.

Thomas Danne (T)

Diabetes Centre for Children and Adolescents, Children's and Youth Hospital "Auf Der Bult", Hannover, Germany.

Bhaswati Mukherjee (B)

Sanofi S.A., Paris, France.

Steve Edelman (S)

University of California, San Diego, CA, USA.

Valerie Pilorget (V)

Sanofi S.A., Paris, France.

Pratik Choudhary (P)

King's College Hospital NHS Foundation Trust, London, UK.
Department of Diabetes, School of Life Course Sciences, King's College London, London, UK.

Eric Renard (E)

Department of Endocrinology, Diabetes and Nutrition, Montpellier University Hospital, University of Montpellier, Montpellier, France.
Institute of Functional Genomics, University of Montpellier, Montpellier, France.
INSERM Clinical Investigation Centre, Montpellier, France.

Richard Bergenstal (R)

International Diabetes Center at Park Nicollet, Minneapolis, USA.

Classifications MeSH